Works by Robbins, Paul F.

Results: 21

mRNA vaccine-induced neoantigen-specific T cell immunity in patients with gastrointestinal cancer.

Published in:

2020

By:

Cafri, Gal;
Gartner, Jared J.;
Zaks, Tal;
Hopson, Kristen;
Levin, Noam;
Paria, Biman C.;
Parkhurst, Maria R.;
Yossef, Rami;
Lowery, Frank J.;
Jafferji, Mohammad S.;
Prickett, Todd D.;
Goff, Stephanie L.;
McGowan, Christine T.;
Seitter, Samantha;
Shindorf, Mackenzie L.;
Parikh, Anup;
Chatani, Praveen D.;
Robbins, Paul F.;
Rosenberg, Steven A.

Publication type:

journal article

Recognition of human gastrointestinal cancer neoantigens by circulating PD-1+ lymphocytes.

Published in:

2019

By:

Gros, Alena;
Tran, Eric;
Parkhurst, Maria R.;
Ilyas, Sadia;
Pasetto, Anna;
Groh, Eric M.;
Robbins, Paul F.;
Yossef, Rami;
Garcia-Garijo, Andrea;
Fajardo, Carlos A.;
Prickett, Todd D.;
Li Jia;
Gartner, Jared J.;
Ray, Satyajit;
Lien Ngo;
Wunderllich, John R.;
Yang, James C.;
Rosenberg, Steven A.;
Jia, Li;
Ngo, Lien

Publication type:

journal article

Neoantigen screening identifies broad TP53 mutant immunogenicity in patients with epithelial cancers.

Published in:

2019

By:

Malekzadeh, Parisa;
Pasetto, Anna;
Robbins, Paul F.;
Parkhurst, Maria R.;
Paria, Biman C.;
Li Jia;
Gartner, Jared J.;
Hill, Victoria;
Yu, Zhiya;
Restifo, Nicholas P.;
Sachs, Abraham;
Tran, Eric;
Lo, Winifred;
Somerville, Robert P. T.;
Rosenberg, Steven A.;
Deniger, Drew C.;
Jia, Li;
Somerville, Robert Pt

Publication type:

journal article

Isolation of neoantigen-specific T cells from tumor and peripheral lymphocytes.

Published in:

2015

By:

Cohen, Cyrille J.;
Gartner, Jared J.;
Horovitz-Fried, Miryam;
Shamalov, Katerina;
Trebska-McGowan, Kasia;
Bliskovsky, Valery V.;
Parkhurst, Maria R.;
Ankri, Chen;
Prickett, Todd. D.;
Crystal, Jessica S.;
Yong F. Li;
El-Gamil, Mona;
Rosenberg, Steven A.;
Robbins, Paul F.;
Li, Yong F

Publication type:

journal article

PD-1 identifies the patient-specific CD8⁺ tumor-reactive repertoire infiltrating human tumors.

Published in:

2014

By:

Gros, Alena;
Robbins, Paul F;
Yao, Xin;
Li, Yong F;
Turcotte, Simon;
Tran, Eric;
Wunderlich, John R;
Mixon, Arnold;
Farid, Shawn;
Dudley, Mark E;
Hanada, Ken-Ichi;
Almeida, Jorge R;
Darko, Sam;
Douek, Daniel C;
Yang, James C;
Rosenberg, Steven A

Publication type:

journal article

PD-1 identifies the patient-specific CD8+ tumor-reactive repertoire infiltrating human tumors.

Published in:

Journal of Clinical Investigation, 2014, v. 124, n. 5, p. 2246, doi. 10.1172/JCI73639

By:

Gros, Alena;
Robbins, Paul F.;
Xin Yao;
Li, Yong F.;
Turcotte, Simon;
Tran, Eric;
Wunderlich, John R.;
Mixon, Arnold;
Farid, Shawn;
Dudley, Mark E.;
Hanada, Ken-ichi;
Almeida, Jorge R.;
Darko, Sam;
Douek, Daniel C.;
Yang, James C.;
Rosenberg, Steven A.

Publication type:

Article

Targeting neoantigens for cancer immunotherapy.

Published in:

International Immunology, 2016, v. 28, n. 7, p. 365, doi. 10.1093/intimm/dxw026

By:

Yong-Chen Lu;
Robbins, Paul F.

Publication type:

Article

Longitudinal Study of Recurrent Metastatic Melanoma Cell Lines Underscores the Individuality of Cancer Biology.

Published in:

Journal of Investigative Dermatology, 2014, v. 134, n. 5, p. 1389, doi. 10.1038/jid.2013.495

By:

Pos, Zoltan;
Spivey, Tara L;
Liu, Hui;
Sommariva, Michele;
Chen, Jinguo;
Wunderlich, John R;
Parisi, Giulia;
Tomei, Sara;
Ayotte, Ben D;
Stroncek, David F;
Malek, Joel A;
Robbins, Paul F;
Rivoltini, Licia;
Maio, Michele;
Chouchane, Lotfi;
Wang, Ena;
Marincola, Francesco M

Publication type:

Article

Definition of the expression of the human carcinoembryonic antigen and non-specific cross-reacting antigen in human breast and lung carcinomas.

Published in:

International Journal of Cancer, 1993, v. 53, n. 6, p. 892, doi. 10.1002/ijc.2910530604

By:

Robbins, Paul F.;
Eggensperger, Diane;
Qi, Chen-Feng;
Schlom, Jeffrey

Publication type:

Article

TIL therapy broadens the tumor-reactive CD8+ T cell compartment in melanoma patients.

Published in:

OncoImmunology, 2012, v. 1, n. 4, p. 409, doi. 10.4161/onci.18851

By:

Kvistborg, Pia;
Chengyi Jenny Shu;
Heemskerk, Bianca;
Fankhauser, Manuel;
Thrue, Charlotte Albæk;
Toebes, Mireille;
van Rooij, Nienke;
Linnemann, Carsten;
van Buuren, Marit M.;
Urbanus, Jos H. M.;
Beltman, Joost B.;
thor Straten, Per;
Li, Yong F.;
Robbins, Paul F.;
Besser, Michal J.;
Schachter, Jacob;
Kenter, Gemma G.;
Dudley, Mark E.;
Rosenberg, Steven A.;
Haanen, John B. A. G.

Publication type:

Article

Dominant B cell epitope from NY-ESO-1 recognized by sera from a wide spectrum of cancer patients: Implications as a potential biomarker.

Published in:

International Journal of Cancer, 2005, v. 114, n. 2, p. 268, doi. 10.1002/ijc.20716

By:

Zeng, Gang;
Aldridge, Michael E.;
Wang, Yu;
Pantuck, Allan J.;
Wang, Allen Y.;
Liu, Yue-xiang;
Han, Yan;
Yuan, Yan-hua;
Robbins, Paul F.;
Dubinett, Steven M.;
deKernion, Jean B.;
Belldegrun, Arie S.

Publication type:

Article

Clonal Persistence and Evolution During a Decade of Recurrent Melanoma.

Published in:

Journal of Investigative Dermatology, 2006, v. 126, n. 6, p. 1372, doi. 10.1038/sj.jid.5700193

By:

Wang, Ena;
Voiculescu, Sonia;
Le Poole, Isabelle C.;
El-Gamil, Mona;
Xin Li;
Sabatino, Marianna;
Robbins, Paul F.;
Nickoloff, Brian J.;
Marincola, Francesco M.

Publication type:

Article

Recognition of NY-ESO-1+ tumor cells by engineered lymphocytes is enhanced by improved vector design and epigenetic modulation of tumor antigen expression.

Published in:

Cancer Immunology, Immunotherapy, 2009, v. 58, n. 3, p. 383, doi. 10.1007/s00262-008-0562-x

By:

Wargo, Jennifer A.;
Robbins, Paul F.;
Yong Li;
Yangbing Zhao;
El-Gamil, Mona;
Caragacianu, Diana;
Zheng, Zhili;
Hong, Julie A.;
Downey, Stephanie;
Schrump, David S.;
Rosenberg, Steven A.;
Morgan, Richard A.

Publication type:

Article

A listing of human tumor antigens recognized by T cells.

Published in:

Cancer Immunology, Immunotherapy, 2001, v. 50, n. 1, p. 3, doi. 10.1007/s002620000169

By:

Renkvist, Nicolina;
Castelli, Chiara;
Robbins, Paul F.;
Parmiani, Giorgio

Publication type:

Article

T Cells Targeting Carcinoembryonic Antigen Can Mediate Regression of Metastatic Colorectal Cancer but Induce Severe Transient Colitis.

Published in:

Molecular Therapy, 2011, v. 19, n. 3, p. 620, doi. 10.1038/mt.2010.272

By:

Parkhurst, Maria R.;
Yang, James C.;
Langan, Russell C.;
Dudley, Mark E.;
Nathan, Debbie-Ann N.;
Feldman, Steven A.;
Davis, Jeremy L.;
Morgan, Richard A.;
Merino, Maria J.;
Sherry, Richard M.;
Hughes, Marybeth S.;
Kammula, Udai S.;
Phan, Giao Q.;
Lim, Ramona M.;
Wank, Stephen A.;
Restifo, Nicholas P.;
Robbins, Paul F.;
Laurencot, Carolyn M.;
Rosenberg, Steven A.

Publication type:

Article

Mining exomic sequencing data to identify mutated antigens recognized by adoptively transferred tumor-reactive T cells.

Published in:

Nature Medicine, 2013, v. 19, n. 6, p. 747, doi. 10.1038/nm.3161

By:

Robbins, Paul F;
Lu, Yong-Chen;
El-Gamil, Mona;
Li, Yong F;
Gross, Colin;
Gartner, Jared;
Lin, Jimmy C;
Teer, Jamie K;
Cliften, Paul;
Tycksen, Eric;
Samuels, Yardena;
Rosenberg, Steven A

Publication type:

Article

Tumor-infiltrating human CD4+ regulatory T cells display a distinct TCR repertoire and exhibit tumor and neoantigen reactivity.

Published in:

Science Immunology, 2019, v. 4, n. 31, p. 1, doi. 10.1126/sciimmunol.aao4310

By:

Ahmadzadeh, Mojgan;
Pasetto, Anna;
Jia, Li;
Deniger, Drew C.;
Stevanović, Sanja;
Robbins, Paul F.;
Rosenberg, Steven A.

Publication type:

Article

NKG2D engagement of colorectal cancer-specific T cells strengthens TCR-mediated antigen stimulation and elicits TCR independent anti-tumor activity.

Published in:

European Journal of Immunology, 2003, v. 33, n. 7, p. 2033, doi. 10.1002/eji.200323909

By:

Maccalli, Cristina;
Pende, Daniela;
Castelli, Chiara;
Mingari, Maria Cristina;
Robbins, Paul F.;
Parmiani, Giorgio

Publication type:

Article

N-linked carbohydrates in tyrosinase are required for its recognition by human MHC class II-restricted CD4.

Published in:

European Journal of Immunology, 2001, v. 31, n. 9, p. 2690, doi. 10.1002/1521-4141(200109)31:9<2690::AID-IMMU2690>3.0.CO;2-8

By:

Housseau, Franck;
Moorthy, Anitha;
Langer, Daniel A.;
Robbins, Paul F.;
Gonzales, Monica I.;
Topalian, Suzanne L.

Publication type:

Article

Memory T cells targeting oncogenic mutations detected in peripheral blood of epithelial cancer patients.

Published in:

Nature Communications, 2019, v. 10, n. 1, p. 1, doi. 10.1038/s41467-019-08304-z

By:

Cafri, Gal;
Yossef, Rami;
Pasetto, Anna;
Deniger, Drew C.;
Lu, Yong-Chen;
Parkhurst, Maria;
Gartner, Jared J.;
Jia, Li;
Ray, Satyajit;
Ngo, Lien T.;
Jafferji, Mohammad;
Sachs, Abraham;
Prickett, Todd;
Robbins, Paul F.;
Rosenberg, Steven A.

Publication type:

Article

MHC class I and class II presentation of tumor antigen in retrovirally and adenovirally transduced dendritic cells.

Published in:

Cancer Gene Therapy, 2002, v. 9, n. 11, p. 946, doi. 10.1038/sj.cgt.7700509

By:

Sloan, J. Mark;
Kershaw, Michael H.;
Touloukian, Christopher E.;
Lapointe, Rejean;
Robbins, Paul F.;
Restifo, Nicholas P.;
Hwu, Patrick

Publication type:

Article

Works by Robbins, Paul F.

mRNA vaccine-induced neoantigen-specific T cell immunity in patients with gastrointestinal cancer.

Recognition of human gastrointestinal cancer neoantigens by circulating PD-1+ lymphocytes.

Neoantigen screening identifies broad TP53 mutant immunogenicity in patients with epithelial cancers.

Isolation of neoantigen-specific T cells from tumor and peripheral lymphocytes.

PD-1 identifies the patient-specific CD8⁺ tumor-reactive repertoire infiltrating human tumors.

PD-1 identifies the patient-specific CD8<sup>+</sup> tumor-reactive repertoire infiltrating human tumors.

Targeting neoantigens for cancer immunotherapy.

Longitudinal Study of Recurrent Metastatic Melanoma Cell Lines Underscores the Individuality of Cancer Biology.

Definition of the expression of the human carcinoembryonic antigen and non-specific cross-reacting antigen in human breast and lung carcinomas.

TIL therapy broadens the tumor-reactive CD8<sup>+</sup> T cell compartment in melanoma patients.

Dominant B cell epitope from NY-ESO-1 recognized by sera from a wide spectrum of cancer patients: Implications as a potential biomarker.

Clonal Persistence and Evolution During a Decade of Recurrent Melanoma.

Recognition of NY-ESO-1+ tumor cells by engineered lymphocytes is enhanced by improved vector design and epigenetic modulation of tumor antigen expression.

A listing of human tumor antigens recognized by T cells.

T Cells Targeting Carcinoembryonic Antigen Can Mediate Regression of Metastatic Colorectal Cancer but Induce Severe Transient Colitis.

Mining exomic sequencing data to identify mutated antigens recognized by adoptively transferred tumor-reactive T cells.

Tumor-infiltrating human CD4<sup>+</sup> regulatory T cells display a distinct TCR repertoire and exhibit tumor and neoantigen reactivity.

NKG2D engagement of colorectal cancer-specific T cells strengthens TCR-mediated antigen stimulation and elicits TCR independent anti-tumor activity.

N-linked carbohydrates in tyrosinase are required for its recognition by human MHC class II-restricted CD4.

Memory T cells targeting oncogenic mutations detected in peripheral blood of epithelial cancer patients.

MHC class I and class II presentation of tumor antigen in retrovirally and adenovirally transduced dendritic cells.